Uploaded September 2023 | Updated November 2026, 8 hours ago
The Introduction to the Principles and Practice of Clinical Research (IPPCR) is a course to train participants on how to effectively conduct clinical research. The course focuses on the spectrum of clinical research and the research process by highlighting epidemiologic methods, study design, protocol preparation, patient monitoring, quality assurance, and Food and Drug Administration (FDA) issues.
The Introduction to the Principles and Practice of Clinical Research (IPPCR) is a course to train participants on how to effectively conduct clinical research. The course focuses on the spectrum of clinical research and the research process by highlighting epidemiologic methods, study design, protocol preparation, patient monitoring, quality assurance, and Food and Drug Administration (FDA) issues.



![Harnessing African Genomic Variations to Improve Health and Equity Globally
Air date: Wednesday, September 14, 2022, 2PM
Description: NIH Director’s Wednesday Afternoon Lecture Series [WALS ]
Prof Ambroise Wonkam is a professor of Genetic Medicine, and Director of the McKusick-Nathans Institute, and Department of Genetic Medicine. After an MD training from the Faculty of Medicine and Biomedical Sciences, University of Yaoundé I (Cameroon), he completed a thesis in Medical Sciences, University of Geneva (Switzerland) and a Ph.D. in Human Genetics (University of Cape Town, South Africa). Other salient aspects of Prof Wonkam’s background include his education as a medical geneticist at a highly reputable genetics department in Geneva (Switzerland). He subsequently practices medical genetics in both European and African contexts.
African genomes harbor millions of uncaptured variants accumulated over 300,000 years of modern humans evolutionary history, with successive waves of admixture, migration, and natural selection combining with extensive ecological diversity to create a broad and exceptional genomic complexity. Therefore to embrace the prospects of accurately diagnosing thousands of monogenic conditions, predicting disease risks for complex traits or diseases, tailoring treatment to individuals pharmacogenetic profiles, and potentially curing some diseases, research into African genomic variation is a scientific imperative.
For more information go to https://oir.nih.gov/wals
Author: Ambroise Wonkam, M.D., Ph.D., Hopkins Medicine
Permanent link: https://videocast.nih.gov/watch=45982 Harnessing African Genomic Variations to Improve Health and Equity Globally](https://i.ytimg.com/vi/bNuUluhiozI/mqdefault.jpg)

![Mutant p53 Activities in Mouse Tumor Models
Air date: Wednesday, December 7, 2022, 3PM
Description: NIH Director’s Wednesday Afternoon Lecture Series [WALS]
Margaret Pittman Lecture
This is the annual WALS–Pittman lecture, but rescheduled from March 2022. Guillermina (Gigi) Lozano is a renowned geneticist recognized for her studies of the p53 tumor suppressor pathway. This pathway is undermined in a large percent of human cancers via mutations and deletions of p53. Her laboratory identified a transcriptional activation function for p53. Using mouse models, her team characterized the physiological importance of Mdm2 and Mdm4 proteins as potent inhibitors of p53. The Mdm proteins are over expressed in many cancers that lack p53 mutations presenting an alternate mechanism of eliminating p53 activity. Other mouse models inheriting the most common p53 mutations revealed gain-of-function phenotypes that drive metastases. Mutation of the p53 gene is a critical event in the elaboration of many tumors of diverse origin. The p53 protein is activated in response to DNA damage, serving as a checkpoint in the elimination or repair of cells with damaged DNA. Alterations in components of the p53 pathway, such as amplification of the Mdm2 gene, which encodes a p53 inhibitor, also contribute to tumorigenesis. The overall goal of my laboratory is to understand the signals that regulate the p53 pathway and the consequences of expressing wild-type or mutant p53.
For more information go to https://oir.nih.gov/wals
Author:
Guillermina Lozano, Ph.D., University of Texas MD Anderson Cancer Center
Permanent link: https://videocast.nih.gov/watch=46003 Mutant p53 Activities in Mouse Tumor Models](https://i.ytimg.com/vi/cAkliNT8CI0/mqdefault.jpg)



![Hematology from the Ground-Up: Lessons from Bloodless Worms
Air date: Wednesday, November 16, 2022, 2PM
Description: NIH Director’s Wednesday Afternoon Lecture Series [WALS]
Our long-term objectives are to identify the genes and pathways responsible for heme transport and trafficking in eukaryotes that have remained poorly understood. Many have a preconceived notion that the bulk of heme biology is well-understood. How does heme, a cytotoxic hydrophobic ring with an iron atom, moves within and between cells? How does heme traffic across cellular membranes and get into hemoglobin? These open questions are enormous holes in our knowledge. The central thrust of our research is to uncover these pathways using a multi-organismal, multi-pronged approach. Our pioneering work with the invertebrate animal model C. elegans demonstrated that this roundworm is exceptional because it does not synthesize heme but rather utilizes environmental heme to manufacture heme-containing proteins that have human homologs. The presentation will highlight efforts in the Hamza lab to understand the mechanistic aspects of heme trafficking as well as how functional insights into these processes lay the groundwork for elucidating the molecular etiology of human disease and parasitic infections.
For more information go to https://oir.nih.gov/wals
Author: Iqbal Hamza, Ph.D., University of Maryland School of Medicine
Permanent link: https://videocast.nih.gov/watch=46015 Hematology from the Ground-Up: Lessons from Bloodless Worms](https://i.ytimg.com/vi/cgcAF7Nvg54/mqdefault.jpg)
